Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2021 Jan 05;1181:. doi: 10.1073/pnas.2020551118.
Show Gene links
Show Anatomy links
Mechanistic insights into the synergistic activation of the RXR-PXR heterodimer by endocrine disruptor mixtures.
Delfosse V
,
Huet T
,
Harrus D
,
Granell M
,
Bourguet M
,
Gardia-Parège C
,
Chiavarina B
,
Grimaldi M
,
Le Mével S
,
Blanc P
,
Huang D
,
Gruszczyk J
,
Demeneix B
,
Cianférani S
,
Fini JB
,
Balaguer P
,
Bourguet W
.
???displayArticle.abstract???
Humans are chronically exposed to mixtures of xenobiotics referred to as endocrine-disrupting chemicals (EDCs). A vast body of literature links exposure to these chemicals with increased incidences of reproductive, metabolic, or neurological disorders. Moreover, recent data demonstrate that, when used in combination, chemicals have outcomes that cannot be predicted from their individual behavior. In its heterodimeric form with the retinoid X receptor (RXR), the pregnane X receptor (PXR) plays an essential role in controlling the mammalian xenobiotic response and mediates both beneficial and detrimental effects. Our previous work shed light on a mechanism by which a binary mixture of xenobiotics activates PXR in a synergistic fashion. Structural analysis revealed that mutual stabilization of the compounds within the ligand-binding pocket of PXR accounts for the enhancement of their binding affinity. In order to identify and characterize additional active mixtures, we combined a set of cell-based, biophysical, structural, and in vivo approaches. Our study reveals features that confirm the binding promiscuity of this receptor and its ability to accommodate bipartite ligands. We reveal previously unidentified binding mechanisms involving dynamic structural transitions and covalent coupling and report four binary mixtures eliciting graded synergistic activities. Last, we demonstrate that the robust activity obtained with two synergizing PXR ligands can be enhanced further in the presence of RXR environmental ligands. Our study reveals insights as to how low-dose EDC mixtures may alter physiology through interaction with RXR-PXR and potentially several other nuclear receptor heterodimers.
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010, Pubmed
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010,
Pubmed
Altenburger,
Mixture effects in samples of multiple contaminants - An inter-laboratory study with manifold bioassays.
2018,
Pubmed
Chai,
Small-molecule modulators of PXR and CAR.
2016,
Pubmed
Chaturvedi,
Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders.
2010,
Pubmed
Coen,
A somatic gene transfer approach using recombinant fusion proteins to map muscle-motoneuron projections in Xenopus spinal cord.
1999,
Pubmed
,
Xenbase
Delfosse,
Synergistic activation of human pregnane X receptor by binary cocktails of pharmaceutical and environmental compounds.
2015,
Pubmed
de Luze,
Thyroid hormone-dependent transcriptional regulation of exogenous genes transferred into Xenopus tadpole muscle in vivo.
1993,
Pubmed
,
Xenbase
Dominguez,
Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
2017,
Pubmed
Egusquiza,
Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.
2020,
Pubmed
Emsley,
Coot: model-building tools for molecular graphics.
2004,
Pubmed
Gallastegui,
Advances in our structural understanding of orphan nuclear receptors.
2015,
Pubmed
García,
Natural ligands of RXR receptors.
2020,
Pubmed
Grün,
Endocrine disrupters as obesogens.
2009,
Pubmed
Grün,
Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.
2006,
Pubmed
,
Xenbase
Kabsch,
XDS.
2010,
Pubmed
Kortenkamp,
Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology.
2008,
Pubmed
Kortenkamp,
Low dose mixture effects of endocrine disrupters and their implications for regulatory thresholds in chemical risk assessment.
2014,
Pubmed
le Maire,
Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors.
2009,
Pubmed
le Maire,
A structural view of nuclear hormone receptor: endocrine disruptor interactions.
2010,
Pubmed
Lin,
SPA70 is a potent antagonist of human pregnane X receptor.
2017,
Pubmed
Martin,
A Human Mixture Risk Assessment for Neurodevelopmental Toxicity Associated with Polybrominated Diphenyl Ethers Used as Flame Retardants.
2017,
Pubmed
Marty,
Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles.
2015,
Pubmed
McAllister,
Early life exposure to environmental levels of the aromatase inhibitor tributyltin causes masculinisation and irreversible sperm damage in zebrafish (Danio rerio).
2003,
Pubmed
Oladimeji,
PXR: More Than Just a Master Xenobiotic Receptor.
2018,
Pubmed
Sui,
Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice.
2014,
Pubmed
Wang,
Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.
2011,
Pubmed
Willson,
PXR, CAR and drug metabolism.
2002,
Pubmed
Xue,
Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition.
2007,
Pubmed
Yan,
A brief history of the discovery of PXR and CAR as xenobiotic receptors.
2016,
Pubmed
Zhao,
A New Bliss Independence Model to Analyze Drug Combination Data.
2014,
Pubmed